Lindsay N. Carpp
0000-0003-0333-5925
Publication & Citation Trends
Publications
0 total
The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances
Cited by 0
Semantic Scholar
A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials
Cited by 2
Semantic Scholar
Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'. EBioMedicine 2024;108: 105320.
Cited by 0
Semantic Scholar
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV
Cited by 1
Semantic Scholar
Analysis of antibody markers as immune correlates of risk of severe COVID-19 in the PREVENT-19 efficacy trial of the NVX-CoV2373 recombinant protein vaccine.
Cited by 0
Semantic Scholar
Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial
Cited by 0
Semantic Scholar
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features OA
Cited by 6
Semantic Scholar
Research Topics
HIV Research and Treatment
(34)
SARS-CoV-2 and COVID-19 Research
(33)
COVID-19 Clinical Research Studies
(18)
vaccines and immunoinformatics approaches
(18)
HIV/AIDS drug development and treatment
(15)
Affiliations
University of Iowa
Center for Infectious Disease Research
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
Infectious Disease Research Institute
University of Washington